Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
726.31B
Market cap726.31B
Price-Earnings ratio
62.20
Price-Earnings ratio62.20
Dividend yield
0.75%
Dividend yield0.75%
Average volume
3.65M
Average volume3.65M
High today
$772.53
High today$772.53
Low today
$753.73
Low today$753.73
Open price
$756.19
Open price$756.19
Volume
3.14M
Volume3.14M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

Simply Wall St 1d
Eli Lilly Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America

recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovar...

Eli Lilly Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America
Sherwood News 6d
Drugmakers beg Trump administration to rethink pharma tariffs

With the exception of specific companies’ beef with Chinese generics, drugmakers were unified in their stance that tariffs aren’t the solution to the country’s...

Drugmakers beg Trump administration to rethink pharma tariffs
Quartz 6d
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescr...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.